» Articles » PMID: 26823053

Gastric Bypass Significantly Improves Quality of Life in Morbidly Obese Patients with Type 2 Diabetes

Overview
Journal Surg Endosc
Publisher Springer
Date 2016 Jan 30
PMID 26823053
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the impact of Roux-en-Y gastric bypass (RYGB) on quality of life in obese diabetic patients compared to standard medical therapy for type 2 diabetes mellitus.

Methods: We prospectively studied two matched obese populations with type 2 diabetes. Thirty patients underwent laparoscopic RYGB and 31 received standard medical therapy combined with a diabetes support and education program (DSE), consisting of educational sessions on diet and exercise. Groups were matched by age, gender, weight, glucostatic parameters, and use of glucose-lowering medications (oral agents and insulin therapy). Health-related quality of life (HRQOL) was assessed using the normalized SF-36 questionnaire, and data were collected at baseline and at 12-month follow-up.

Results: Diabetic patients who underwent RYGB experienced a statistically significant increase in their overall HRQOL. However, the role-physical and mental health domains increased but did not reach statistical significance. Diabetic patients in the medical therapy and DSE group did not show any significant increase in HRQOL. The between-group differences for the HRQOL changes from baseline were significant, other than for role-physical and mental health domains. Percentage changes in glucostatic parameters, discontinuation of glucose-lowering medications, and T2DM remission were not found to predict the percentage change in SF-36 scores at 12 months after RYGB.

Conclusions: For the first time, with a prospective matched control study, we demonstrate a significant improvement in HRQOL in obese diabetic patients who underwent RYGB, but not in those who were offered standard medical therapy and DSE.

Citing Articles

Long-term impact of the metabolic status on weight loss-induced health benefits.

Soll D, Gawron J, Pletsch-Borba L, Spranger J, Mai K Nutr Metab (Lond). 2022; 19(1):25.

PMID: 35346256 PMC: 8962471. DOI: 10.1186/s12986-022-00660-w.


Distal gastrectomy for gastric carcinoma in patients with diabetes mellitus: impact of reconstruction type on glucose tolerance.

Nakamura K, Suda K, Suzuki A, Nakauchi M, Shibasaki S, Kikuchi K Fujita Med J. 2022; 5(1):1-8.

PMID: 35111493 PMC: 8766235. DOI: 10.20407/fmj.2018-004.


Quality of Life After Bariatric Surgery-a Systematic Review with Bayesian Network Meta-analysis.

Malczak P, Mizera M, Lee Y, Pisarska-Adamczyk M, Wysocki M, Bala M Obes Surg. 2021; 31(12):5213-5223.

PMID: 34633614 PMC: 8595157. DOI: 10.1007/s11695-021-05687-1.


Effects of a High-Intensity Exercise Program on Weight Regain and Cardio-metabolic Profile after 3 Years of Bariatric Surgery: A Randomized Trial.

Marc-Hernandez A, Ruiz-Tovar J, Aracil A, Guillen S, Moya-Ramon M Sci Rep. 2020; 10(1):3123.

PMID: 32080310 PMC: 7033151. DOI: 10.1038/s41598-020-60044-z.


Racial Disparity in 30-Day Outcomes of Metabolic and Bariatric Surgery.

Amirian H, Torquati A, Omotosho P Obes Surg. 2019; 30(3):1011-1020.

PMID: 31745861 PMC: 7222128. DOI: 10.1007/s11695-019-04282-9.


References
1.
. Standards of medical care in diabetes--2013. Diabetes Care. 2012; 36 Suppl 1:S11-66. PMC: 3537269. DOI: 10.2337/dc13-S011. View

2.
Ware J, Kosinski M . Interpreting SF-36 summary health measures: a response. Qual Life Res. 2002; 10(5):405-13; discussion 415-20. DOI: 10.1023/a:1012588218728. View

3.
Kolotkin R, Norquist J, Crosby R, Suryawanshi S, Teixeira P, Heymsfield S . One-year health-related quality of life outcomes in weight loss trial participants: comparison of three measures. Health Qual Life Outcomes. 2009; 7:53. PMC: 2700089. DOI: 10.1186/1477-7525-7-53. View

4.
Bergman R, Finegood D, Ader M . Assessment of insulin sensitivity in vivo. Endocr Rev. 1985; 6(1):45-86. DOI: 10.1210/edrv-6-1-45. View

5.
Dixon J, Dixon M, OBrien P . Quality of life after lap-band placement: influence of time, weight loss, and comorbidities. Obes Res. 2001; 9(11):713-21. DOI: 10.1038/oby.2001.96. View